Cerus And 2 Other Compelling Penny Stocks To Watch

The market remained flat over the last week, but it has shown a 12% rise over the past year, with earnings forecasted to grow by 17% annually. For investors who look beyond well-known stocks, penny stocks—typically representing smaller or newer companies—can offer intriguing possibilities. Despite being an outdated term, penny stocks remain relevant as they often present opportunities for growth when backed by strong financial health.

Here's a peek at a few of the choices from the screener.

Cerus (CERS)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Cerus Corporation is a biomedical products company with a market cap of $464.51 million.

Operations: The company generates revenue primarily from its Blood Safety segment, which accounted for $221.55 million.

Market Cap: $464.51M

Cerus Corporation, with a market cap of US$464.51 million, primarily generates revenue from its Blood Safety segment, totaling US$221.55 million. Despite being unprofitable, the company has reduced losses over the past five years at a rate of 30.8% annually and forecasts earnings growth of 69.84% per year. Recent guidance raised product revenue expectations for 2026 to between US$229 million and US$231 million. Cerus maintains a satisfactory net debt to equity ratio of 12.2%, with short-term assets exceeding liabilities, providing a cash runway for more than three years despite increased debt levels over time.

• Dive into the specifics of Cerus here with our thorough balance sheet health report.
• Evaluate Cerus' prospects by accessing our earnings growth report.

SoundHound AI (SOUN)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: SoundHound AI, Inc. offers independent voice artificial intelligence solutions for various industries including automotive and customer service, with a market cap of approximately $2.09 billion.

Operations: The company generated $203.2 million in revenue from its Internet Software & Services segment.

Market Cap: $2.09B

SoundHound AI, Inc., with a market cap of US$2.09 billion, is expanding its voice AI technology in automotive and other sectors. Recent deployments include the Kia Sorento in India and the launch of OASYS Edge for embedded AI applications. Despite generating US$203.2 million in revenue from Internet Software & Services, it remains unprofitable with a negative return on equity of -27.95%. The company has sufficient cash runway for over two years but faces significant insider selling and earnings are expected to decline by 26.3% annually over the next three years despite raised revenue guidance for 2026 to US$230-260 million.

• Click to explore a detailed breakdown of our findings in SoundHound AI's financial health report.
• Understand SoundHound AI's earnings outlook by examining our growth report.

Blend Labs (BLND)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Blend Labs, Inc. offers a cloud-based software platform for financial services firms across the United States, India, and Mexico with a market cap of approximately $233.39 million.

Operations: The company's revenue is primarily derived from its Blend Platform, which generated $129.79 million.

Market Cap: $233.39M

Blend Labs, Inc. is enhancing its cloud-based software platform with innovations like Blend Autopilot, which has seen increased adoption among lenders, handling nearly 200,000 loans annually. The company remains unprofitable but is reducing losses and maintains a strong cash runway for over three years due to positive free cash flow. Despite recent volatility in share price and being dropped from the S&P Software & Services Select Industry Index, Blend's short-term assets cover both its short- and long-term liabilities comfortably. Recent partnerships aim to modernize mortgage experiences while strategic buybacks have reduced outstanding shares by 8.85%.

• Get an in-depth perspective on Blend Labs' performance by reading our balance sheet health report here.
• Examine Blend Labs' earnings growth report to understand how analysts expect it to perform.

Summing It All Up

• Dive into all 323 of the US Penny Stocks we have identified here.
• Ready To Venture Into Other Investment Styles? The end of cancer? These 38 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com